바이오테크

Biotech company Guard Therapeutics has received conditional approval from Nasdaq Stockholm for continued listing of its shares on Nasdaq First North.

2026년 07월 12일 AI에 의해 보고됨

Researchers have demonstrated that quantum computers can enhance generative Artificial Intelligence models for drug discovery. The work focused on generating new peptides and was completed as a side project using leftover resources.

Brain implant developer Paradromics has secured approval from the US Food and Drug Administration to conduct an early-stage human trial for its device. The Austin-based startup aims to test the high-bandwidth implant to restore speech in individuals with extremely limited movement. The company announced the milestone on Thursday.

2025년 11월 08일 AI에 의해 보고됨

An experimental gene-editing therapy from Crispr Therapeutics has successfully reduced high cholesterol levels in a small group of patients. This development marks a step toward broader applications of Crispr technology in treating heart disease.

A new treatment tested in brain organoids with glioblastoma outperformed chemotherapy and dramatically reduced tumors in mice. Human trials are upcoming. The approach also explores stem cell stimulation and aging cell rejuvenation for broader immunotherapy applications.

2025년 09월 11일 AI에 의해 보고됨

Summit's new drug for lung cancer demonstrated promising results in recent assessments. This development is part of ongoing biotech advancements in oncology. It was reported alongside other health innovations.